Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 70518-3844

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 70518-3844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description for Buprenorphine/Naloxone, a medication available in the form of sublingual tablets. Each tablet contains 8mg of Buprenorphine and 2mg of Naloxone. The prescription is for 30 tablets. The medication is intended for sublingual (under the tongue) use. The NDC number is 70518-3844-00 and the manufacturer is Hikma Pharma in Amman, Jordan. The medication should be stored in a cool place between 20-25°C (58-77°F), with some permitted temperature excursions. The repackaging is done by RemedyRepack Inc., located in Indiana, PA. Please refer to the package insert for directions for use.*

FDA Label Image

Buprenorphine-chem-structure.jpg (Image 02)

FDA Label Image

Bupr-naloxone-ifu-mouth-image (Image 03)

FDA Label Image

Naloxone-chem-structure.jpg (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.